Lululemon barely increased revenue in a key geographic region.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 07 Sept 2025, 21:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The video presents a fundamental analysis of Lululemon (LULU) stock following a recent 18% price drop after disappointing quarterly financial results. Despite expressing disappointment and acknowledging the stock's underperformance in 2025, the analyst maintains a "buy" rating. The analysis mentions net revenue increased 7% to $2.5 billion, and international net revenue increased 22%. However, revenue in the Americas only increased by 1%. It is expected by the analyst for the management team to lean into international business due to high tariffs impacting US business. Gross profit margin is reported to decrease, but its cost of capital decreased, as the risk free rate dropped. The management also repurchased 1.1 million of its shares for a cost of $278.5 million, The video concludes the shares are undervalued and the recommendation is to buy the stock, the target price being 241.07 dollars.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
